Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis

Anna M. Smedts, Subodh M. Lele, Susan C. Modesitt, Thomas E. Curry

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To characterize the expression of basigin in ovarian endometriotic tissue, normal ovary, and endometrium during the menstrual cycle. Design: Controlled, retrospective study for evaluation of basigin expression in archived specimens. Setting: Academic research environment: University of Kentucky College of Medicine. Patient(s): Archived surgical specimens selected by retrospective chart review of age-matched (39 ± 2.5 years) patients with and without ovarian endometriosis. Intervention(s): None. Main Outcome Measure(s): Expression localization of basigin mRNA and protein. Result(s): Basigin (mRNA and protein) was localized to granulosa cells (follicles of all stages), the ovarian surface epithelium, and granulosa and theca lutein of corpora lutea. Differential patterns of expression were apparent among samples of eutopic endometrium collected during the proliferative and secretory stages. In endometriotic lesions on the ovary, basigin was detected in the glandular epithelia and stroma of proliferative and secretory phase samples, but patterns of expression were unsynchronized with those of the eutopic endometrium from the same patient. Conclusion(s): The current data demonstrate unique expression patterns of basigin in the human ovary and endometriotic tissue, thereby supporting a possible role in normal ovarian function and in the dysregulation of proteolytic matrix metalloproteinases in endometriosis.

Original languageEnglish (US)
Pages (from-to)535-542
Number of pages8
JournalFertility and Sterility
Volume86
Issue number3
DOIs
StatePublished - Sep 1 2006

Fingerprint

CD147 Antigens
Endometriosis
Ovary
Endometrium
Epithelium
Lutein
Messenger RNA
Granulosa Cells
Corpus Luteum
Menstrual Cycle
Matrix Metalloproteinases
Retrospective Studies
Medicine
Outcome Assessment (Health Care)
Research

Keywords

  • Basigin
  • CD147
  • EMMPRIN
  • matrix metalloproteinase
  • ovarian endometriosis

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis. / Smedts, Anna M.; Lele, Subodh M.; Modesitt, Susan C.; Curry, Thomas E.

In: Fertility and Sterility, Vol. 86, No. 3, 01.09.2006, p. 535-542.

Research output: Contribution to journalArticle

@article{9b117f54db7b4bb68ea72de18a6e367a,
title = "Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis",
abstract = "Objective: To characterize the expression of basigin in ovarian endometriotic tissue, normal ovary, and endometrium during the menstrual cycle. Design: Controlled, retrospective study for evaluation of basigin expression in archived specimens. Setting: Academic research environment: University of Kentucky College of Medicine. Patient(s): Archived surgical specimens selected by retrospective chart review of age-matched (39 ± 2.5 years) patients with and without ovarian endometriosis. Intervention(s): None. Main Outcome Measure(s): Expression localization of basigin mRNA and protein. Result(s): Basigin (mRNA and protein) was localized to granulosa cells (follicles of all stages), the ovarian surface epithelium, and granulosa and theca lutein of corpora lutea. Differential patterns of expression were apparent among samples of eutopic endometrium collected during the proliferative and secretory stages. In endometriotic lesions on the ovary, basigin was detected in the glandular epithelia and stroma of proliferative and secretory phase samples, but patterns of expression were unsynchronized with those of the eutopic endometrium from the same patient. Conclusion(s): The current data demonstrate unique expression patterns of basigin in the human ovary and endometriotic tissue, thereby supporting a possible role in normal ovarian function and in the dysregulation of proteolytic matrix metalloproteinases in endometriosis.",
keywords = "Basigin, CD147, EMMPRIN, matrix metalloproteinase, ovarian endometriosis",
author = "Smedts, {Anna M.} and Lele, {Subodh M.} and Modesitt, {Susan C.} and Curry, {Thomas E.}",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.fertnstert.2006.01.042",
language = "English (US)",
volume = "86",
pages = "535--542",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis

AU - Smedts, Anna M.

AU - Lele, Subodh M.

AU - Modesitt, Susan C.

AU - Curry, Thomas E.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Objective: To characterize the expression of basigin in ovarian endometriotic tissue, normal ovary, and endometrium during the menstrual cycle. Design: Controlled, retrospective study for evaluation of basigin expression in archived specimens. Setting: Academic research environment: University of Kentucky College of Medicine. Patient(s): Archived surgical specimens selected by retrospective chart review of age-matched (39 ± 2.5 years) patients with and without ovarian endometriosis. Intervention(s): None. Main Outcome Measure(s): Expression localization of basigin mRNA and protein. Result(s): Basigin (mRNA and protein) was localized to granulosa cells (follicles of all stages), the ovarian surface epithelium, and granulosa and theca lutein of corpora lutea. Differential patterns of expression were apparent among samples of eutopic endometrium collected during the proliferative and secretory stages. In endometriotic lesions on the ovary, basigin was detected in the glandular epithelia and stroma of proliferative and secretory phase samples, but patterns of expression were unsynchronized with those of the eutopic endometrium from the same patient. Conclusion(s): The current data demonstrate unique expression patterns of basigin in the human ovary and endometriotic tissue, thereby supporting a possible role in normal ovarian function and in the dysregulation of proteolytic matrix metalloproteinases in endometriosis.

AB - Objective: To characterize the expression of basigin in ovarian endometriotic tissue, normal ovary, and endometrium during the menstrual cycle. Design: Controlled, retrospective study for evaluation of basigin expression in archived specimens. Setting: Academic research environment: University of Kentucky College of Medicine. Patient(s): Archived surgical specimens selected by retrospective chart review of age-matched (39 ± 2.5 years) patients with and without ovarian endometriosis. Intervention(s): None. Main Outcome Measure(s): Expression localization of basigin mRNA and protein. Result(s): Basigin (mRNA and protein) was localized to granulosa cells (follicles of all stages), the ovarian surface epithelium, and granulosa and theca lutein of corpora lutea. Differential patterns of expression were apparent among samples of eutopic endometrium collected during the proliferative and secretory stages. In endometriotic lesions on the ovary, basigin was detected in the glandular epithelia and stroma of proliferative and secretory phase samples, but patterns of expression were unsynchronized with those of the eutopic endometrium from the same patient. Conclusion(s): The current data demonstrate unique expression patterns of basigin in the human ovary and endometriotic tissue, thereby supporting a possible role in normal ovarian function and in the dysregulation of proteolytic matrix metalloproteinases in endometriosis.

KW - Basigin

KW - CD147

KW - EMMPRIN

KW - matrix metalloproteinase

KW - ovarian endometriosis

UR - http://www.scopus.com/inward/record.url?scp=33748109215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748109215&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2006.01.042

DO - 10.1016/j.fertnstert.2006.01.042

M3 - Article

C2 - 16876164

AN - SCOPUS:33748109215

VL - 86

SP - 535

EP - 542

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -